Efficacy, safety and administration timing of trastuzumab in human epidermal growth factor receptor 2 positive breast cancer patients: A meta-analysis
about
Risk of gastrointestinal complications in breast cancer patients treated with neratinib: a meta-analysis.The incidence and management of cutaneous adverse events of the epidermal growth factor receptor inhibitors.Dual targeting of HER2-positive breast cancer with trastuzumab emtansine and pertuzumab: understanding clinical trial resultsEfficacy and cardiac safety of the concurrent use of trastuzumab and anthracycline-based neoadjuvant chemotherapy for HER2-positive breast cancer: a systematic review and meta-analysis
P2860
Efficacy, safety and administration timing of trastuzumab in human epidermal growth factor receptor 2 positive breast cancer patients: A meta-analysis
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Efficacy, safety and administr ...... ncer patients: A meta-analysis
@en
type
label
Efficacy, safety and administr ...... ncer patients: A meta-analysis
@en
prefLabel
Efficacy, safety and administr ...... ncer patients: A meta-analysis
@en
P2093
P2860
P356
P1476
Efficacy, safety and administr ...... ncer patients: A meta-analysis
@en
P2093
Fang-Fang Chen
Lin-Wei Wang
Yuan-Yuan Chen
P2860
P304
P356
10.3892/ETM.2016.3095
P577
2016-02-19T00:00:00Z